ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Surgery Improves Survival For Women With Metastatic Breast Cancer At Diagnosis

May 26, 2006

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

House panel investigating NIH handling of tissue specimens.

June 24, 2005

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.

February 25, 2000

High Risk workshop Planned To Produce Monograph On Current Knowledge

October 11, 1974